Sensorion will present at the Bioprocessing Summit Europe virtual conference on July 21-23, 2020. pdfRead

Sensorion Hosting Key Opinion Leader Call with Dr. Michael Hoffer on Sudden Sensorineural Hearing Loss and SENS-401 as a Potential Treatment Option on July 23, 2020. pdfRead

Sensorion appoints Dr Edwin Moses, former Ablynx CEO, as Chairman of the Board. pdfRead

Sensorion announces initiation of coverage by US investment bank Chardan with a "Buy" recommendation. pdfRead

Sensorion announces positive preliminary preclinical data from its Otoferlin gene therapy program. pdfRead


20200910 pipeline


Patient center

Corporate presentation